ALK International needs you to invest in hope today and donate to vital medical research into ALK cancer.
Like, share and follow us across all social media platforms to show your support 💙🩵🩷
Whatever you do, big or small makes a difference, join us and take #ACTION4ALK
ALK International are now signed up to Recycle4charity! ♻️🦑
Recycle4Charity is a free programme for empty ink cartridges!- help the environment whilst raising money for much-needed research into ALK cancer! Donations of up to £2 per ink cartridge
recycle4charity.co.uk/regist…
MARIPOSA shows a 25% OS benefit for amivantamab lazertinib vs osimertinib in newly diagnosed EGFR advanced #lungcancer.
A big moment—but not a simple one. Side effects, IV treatment & QoL all matter.
And right now, this option isn’t available for those in our UK EGFR community.
Full results Weds at #ELCC25#LCSMprnewswire.com/news-releases…
Dr. Edward Garon discusses the circumstances that might lead him to switch a patient with ALK NSCLC from another ALK inhibitor to lorlatinib. #NSCLCcancernetwork.com/view/evalu…
The review's deep dive into ALK's oncogenic role and emerging resistance to inhibitors is a call to action for innovative cancer therapies. As a cardiologist, I champion the need for sustained research investment, crucial for advancing patient care amidst the UK's challenging funding landscape.
Ultra-deep sequencing of high-risk neuroblastomas found oncogenic aberrations are more prevalent at diagnosis than once thought. ALK and RAS pathway aberrations confer inferior outcomes, emphasizing the need for novel therapeutic approaches. ascopost.com/news/march-2025…
ALK International is looking for Volunteers!
Passionate about ALK cancer research? Social media experience? Want to get involved with advocacy?
If you believe that research saves lives come and join our team and help us further ALK cancer research.
#Action4Alk#TogetherWeCan
We at @cancerGRACE are fortunate to have @ChristineBestv1 from @UCCancerCenter speaking on ALK, ROS1, and RET at our Targeted Therapies forum. She has become deservedly recognized for her thoughtful commentary in many areas of lung cancer. Many options to consider here.
🎙 NEW PODCAST EPISODE! The Riddle Of Drug Response. Today, we speak with Dr. Zachary Rogers, a post-doctoral researcher at MIT’s Koch Institute, whose work on ALK mutations illuminates these advancements. Listen: upstagelungcancer.org/podcas… & on all podcast platforms!
#Lilly#Bayer
There is still lots of time to donate and invest in hope for a better future for ALK cancer patients.
Ways to donate:
🩵Leave a legacy in your will
💙Add gift aid to your donation
🩷Create a monthly direct debit
🩵Talk to your employer and add payroll giving
💙Alternatively you can generate free donations via EasyFundraising, Buy2Give, GiveAsYouLive, etc.
🩷Making a donation is easy through Facebook or Instagram using the Meta platform. You can also donate via Paypal, JustGiving or our preferred charity platform Kindlink,